Back to the top

American Cancer Society and 𝖡𝗋𝖾𝖺𝗄 𝘛𝘩𝘳𝘰𝘶𝘨𝘩 𝖢𝖺𝗇𝖼𝖾𝗋 Unite to Outsmart Ovarian Cancer

American Cancer Society and Break Through Cancer Unite to Outsmart Ovarian Cancer In recognition of Ovarian Cancer Awareness Month, two leading cancer research organizations to collaborate to bring decades of scientific research into clinical practice News Release For Immediate Release Media Contact: Michele Money-Carson, Michele.Money-Carson@cancer.org Kari McHugh, kari.mchugh@breakthroughcancer.org ATLANTA, September 25, 2025 – More than 20,000 new cases of ovarian cancer will be diagnosed in the United States this year, and more than 12,000 women are expected to die from the disease. Today, the American Cancer Society (ACS) and Break Through Cancer are announcing a strategic collaboration that will aim......

Continue reading

Accelerating Discovery: 𝖡𝗋𝖾𝖺𝗄 𝘛𝘩𝘳𝘰𝘶𝘨𝘩 𝖢𝖺𝗇𝖼𝖾𝗋’𝗌 2nd Annual Hackathon

Accelerating Discovery: Break Through Cancer’s 2nd Annual Hackathon This June, Break Through Cancer hosted its 2nd Annual Hackathon at the Broad Institute, bringing together 67 participants across seven TeamLabs for two days of intense, cross-disciplinary problem solving. Researchers, clinicians, data coordinators, and Break Through Cancer staff worked side by side to tackle some of the most pressing analytical challenges across glioblastoma, ovarian, and pancreatic cancer.   Radical Collaboration in Action Hackathons are designed to spark innovation by bringing together people who don’t normally sit in the same room. For Break Through Cancer, they are a natural extension of our TeamLab......

Continue reading

Break Through Cancer Launches Largest-Ever Investment in Pediatric Osteosarcoma Research

Break Through Cancer Launches Largest-Ever Investment in Pediatric Osteosarcoma Research Backed by a $15 million investment, families, funders, and researchers unite to advance long-awaited breakthroughs against this deadly childhood bone cancer News Release For Immediate Release Media Contact: Soracha Ward soracha.ward@breakthroughcancer.org (CAMBRIDGE, MASS.) September 18, 2025 – Supported by patient-driven foundations, eight leading research institutions, including over 20 researchers, and a $15 million dollar investment, Break Through Cancer’s Defying Osteosarcoma TeamLab mobilizes the largest, most unified effort in pediatric osteosarcoma research in North America. While other cancers have benefited from waves of innovation and precision medicine, the standard chemotherapy treatment......

Continue reading

New Study Finds Hidden Disease in Nearly Half of Ovarian Cancer Patients in ‘Remission’

New Study Finds Hidden Disease in Nearly Half of Ovarian Cancer Patients in ‘Remission’ Using minimally invasive surgery and blood tests Break Through Cancer TeamLab found cancer cells, new drug targets, and biological clues for future therapies News Release For Immediate Release Media Contact: Soracha Ward soracha.ward@breakthroughcancer.org (CAMBRIDGE, MASS.) August 01, 2025 – Survival rates for advanced ovarian cancer have remained stagnant for over four decades, largely because it so often recurs. While patients respond well to initial surgery and chemotherapy, it comes back in 4 out of 5 cases. A new Break Through Cancer study published in Clinical Cancer......

Continue reading

Can Early Intervention Prevent Leukemia? New Trial Gives Patients a Choice Beyond the Current ‘Wait and See’ Approach

Can Early Intervention Prevent Leukemia? New Trial Gives Patients a Choice Beyond the Current ‘Wait and See’ Approach Scientists are exploring if early intervention can prevent AML in high-risk patients, shifting the focus from monitoring to proactive prevention News Release For Immediate Release Media Contact: Soracha Ward soracha.ward@breakthroughcancer.org (CAMBRIDGE, MASS.) July 10, 2025 – Break Through Cancer, a Boston-based cancer research foundation, has launched a clinical trial to evaluate the feasibility of early intervention for Clonal Hematopoiesis (CH), a precursor to acute myeloid leukemia (AML). This multi-institutional study focuses on high-risk patients, exploring a new approach to managing this pre-malignant......

Continue reading

Break Through Cancer
101 Rogers Street
Suite 3A
Cambridge, MA 02142
Info@breakthroughcancer.org
1-800-757-9881

Charity Navigator Four Star Rating